These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


998 related items for PubMed ID: 17583388

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
    Sulthana MT, Alagarsamy V, Chitra K.
    Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
    Gunasekaran P, Perumal S, Yogeeswari P, Sriram D.
    Eur J Med Chem; 2011 Sep; 46(9):4530-6. PubMed ID: 21839549
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains.
    Kumar S, Dwivedi AP, Kashyap VK, Saxena AK, Dwivedi AK, Srivastava R, Sahu DP.
    Bioorg Med Chem Lett; 2013 Apr 15; 23(8):2404-7. PubMed ID: 23474387
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives.
    Turan-Zitouni G, Kaplancikli ZA, Yildiz MT, Chevallet P, Kaya D.
    Eur J Med Chem; 2005 Jun 15; 40(6):607-13. PubMed ID: 15922844
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synthesis and anticonvulsant activity of new N-(alkyl/sub-stituted aryl)-N'-[4-(5-cyclohexylamino)-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
    Karakus S, Koçyiğit-Kaymakcioğlu B, Toklu HZ, Aricioglu F, Rollas S.
    Arch Pharm (Weinheim); 2009 Jan 15; 342(1):48-53. PubMed ID: 19035387
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
    Sriram D, Yogeeswari P, Dinakaran M, Banerjee D, Bhat P, Gadhwal S.
    Eur J Med Chem; 2010 Jan 15; 45(1):120-3. PubMed ID: 19942326
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis, and anti-HCV activity of thiourea compounds.
    Kang IJ, Wang LW, Lee CC, Lee YC, Chao YS, Hsu TA, Chern JH.
    Bioorg Med Chem Lett; 2009 Apr 01; 19(7):1950-5. PubMed ID: 19251415
    [Abstract] [Full Text] [Related]

  • 40. Efficient regioselective three-component domino synthesis of 3-(1,2,4-Triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents.
    El Bialy SA, Nagy MM, Abdel-Rahman HM.
    Arch Pharm (Weinheim); 2011 Dec 01; 344(12):821-9. PubMed ID: 21932255
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 50.